Citations

Clear

168 citation(s) found for "Houghton, L A".

Beyond platelet counts: assessing safety of postsplenectomy TPO-RA use in ITP
Alyamany, Ruah , Houghton, Damon E. , Sridharan, Meera , Pruthi, Rajiv K. , Shah, Surbhi , Wolanskyj-Spinner, Alexandra P , Houghton, Damon E , Sridharan, Meera , Godby, Richard , Wolanskyj, Alexandra P. , Go, Ronald S.

Mayo Clinic

Blood Advances | August 28, 2025 | Volume: 9 | Issue: 22 | Pages: 5902-5912

10.1182/bloodadvances.2025017902 | PMID 40875595 Get It

Abstract Immune thrombocytopenia (ITP) carries an increased risk of thrombosis, which may be further amplified by splenectomy and thrombopoietin receptor agonists (TPO-RAs). Although each intervention has been individually studied for its thrombotic risk, data are lacking on the safety of postsplenectomy TPO-RA use. We conducted a retrospective cohort study of adult patients with ITP who underwent splenectomy between 2011 and 2024. Patients were stratified on the basis of postsplenectomy TPO-RA use. The primary outcome was incidence of thrombosis. Secondary outcomes included bleeding, mortality, and hematologic response. Time-to-event analyses and multivariate Cox regression were performed. Among 88 patients, 37 (42%) patients received TPO-RAs after splenectomy. Thrombosis occurred in 17 patients in the TPO-RA group vs 14 patients in the non–TPO-RA group (P = .07). The 10-year cumulative incidence of thrombosis was numerically higher in the TPO-RA group (57% vs 36%), with clustering of events within the 3 months of postsplenectomy TPO-RA initiation. Venous events predominated; arterial events were rare. No significant differences were observed in bleeding or mortality rates between groups. Platelet counts alone did not independently affect bleeding or thrombosis. TPO-RA use after splenectomy was not significantly associated with increased thrombosis risk. However, early initiation may coincide with a high-risk period, and the sustained numerical difference in cumulative incidence throughout follow-up highlights potential clinical relevance. These findings support the need for individualized thromboprophylaxis and prospective evaluation of TPO-RA safety in this setting.
Cardiovascular and aortic wave reflection responses to evening binge alcohol consumption
Thiverge, Grant S, Greenlund, Ian M. , Bigalke, Jeremy A. , Smoot, Carl A., Durocher, John J. , Carter, Jason R , Durocher, John J , Bigalke, Jeremy A , Thivierge, Grant S., Carter, Jason R.

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | August 1, 2025 | Volume: 329 | Issue: 3 | Pages: H629-H635

10.1152/ajpheart.00466.2025 | PMID 40748681 Get It

Increases in aortic wave reflection and aortic pulsatile load are known contributors to hypertension, cardiovascular risk, and pulsatile stress to end organs. To our knowledge, this is the first study to demonstrate that evening binge alcohol consumption increases heart rate, aortic pulsatile load, and aortic augmentation index the following morning when compared with fluid control. These findings highlight the deleterious overnight cardiovascular effects of binge alcohol consumption in young adults.
Venous Thromboembolism Outcomes Among Cancer and Non-cancer Patients Managed with Patient-centric Guideline-driven Protocol
Cassianni, Claire , Vlazny, Danielle T. , Hodge, David O. , Cassianni, Claire E , McBane, Robert D. , Casanegra, Ana I. , Houghton, Damon E. , Wysokiński, Waldemar E.

Mayo Clinic

Thrombosis and Haemostasis | July 25, 2025 | Volume: 126 | Issue: 05 | Pages: 518-525

10.1055/a-2653-6161 | PMID 40719144 Get It

Abstract Patients with cancer and venous thromboembolism (VTE) have higher complication rates of anticoagulation. However, studies supporting this data are relatively old reflecting the era of vitamin K inhibitors. To assess VTE recurrence, major bleeding, and clinically relevant non-major bleeding (CRNMB) in patients (March 1, 2013 to April 30, 2023) with cancer-associated VTE and patients without cancer, the prospective Mayo Clinic Thrombophilia Clinic Registry was analyzed. Over the study period, 4,711 patients with acute VTE were enrolled including 2,064 patients with cancer (mean age 62.5 ± 12.4, 46% female) and 2,647 patients without cancer (mean age 59.4 ± 16.0, 45% female). The most common cancers were gastrointestinal (n = 423, 21%), pancreatic (n = 287, 14%), and genitourinary (n = 198, 10%). Direct oral anticoagulants were used in 1,339 (65%) cancer and in 1,952 (74%) non-cancer patients. Among cancer patients, 12-month Kaplan–Meier probability of VTE recurrence was 2.4-fold greater (7.1% vs. 2.9%, p < 0.001) compared with the non-cancer group, including higher recurrent leg deep vein thrombosis (3.0% vs. 1.4%; p = 0.002) and pulmonary embolism (3.5% vs. 1.0%, p < 0.001). Patients with cancer also had 2.1-fold greater risk of major bleeding (6.3% vs. 3.0%; p < 0.001) including bleeding from the gastrointestinal tract (3.0 vs. 1.4, p = 0.01) compared with patients without cancer. Clinically relevant non-major bleeding events were similar between the groups. In this large prospective registry of VTE management, patients with cancer had significantly higher rates of VTE recurrence and major bleeding compared with patients without cancer, yet the rate of complications are substantially smaller relative to historic values of a prior vitamin K antagonist era.
Comparison of Flow Dynamics After Left Atrial Appendage Occlusion With the Watchman FLX Versus Amulet Devices: Implications for Device‐Related Thrombosis
Bshennaty, Ahmad , Vogl, Brennan , Bavo, Alessandra , Ghazal‐Aswad, Karam, Kramer, Anders , Jia, Yuheng , Beule, Matthieu De , Nielsen‐Kudsk, Jens Erik , Saleh, Ghasaq, Bavo, Alessandra Maria , Sularz, Agata , Ghazal-Aswad, Karam, Jia, Yuheng , De Backer, Ole , Hatoum, Hoda , Kramer, Anders Dahl , Saleh, Ghasaq , Sularz, Agata , Backer, Ole De , Alkhouli, Mohamad , Hatoum, Hoda

Mayo Clinic

Catheterization and Cardiovascular Interventions | June 25, 2025 | Volume: 106 | Issue: 4 | Pages: 2084-2092

10.1002/ccd.31710 | PMID 40556123 Get It

ABSTRACT Background This study aims to assess how Watchman FLX (Boston Scientific) and Amplatzer Amulet (Abbott) devices for left atrial appendage occlusion (LAAO) impact the flow dynamics in the LA and the risk of device‐related thrombosis (DRT). Methods Flow simulations were carried out for 12 AF patients before and after undergoing LAAO. Six patients had Watchman FLX while the other six had Amulet devices, of which three in each group had DRT. The flow parameters investigated included the LA velocities, pressure, time averaged wall shear stress (TAWSS), oscillatory shear index (OSI), and relative residence time (RRT). Low TAWSS and high OSI and RRT are generally associated with flow stasis and thrombosis. Results LA flow dynamics differed significantly between the two groups. On average, after LAAO, the Amulet patients exhibited a 25% increase in TAWSS and 24% decrease in RRT while the Watchman FLX patients exhibited, on average, a 24% decrease in TAWSS and a 23% increase in RRT. Both populations experienced an increase in LA pressure (~10% for Amulet patients and 16% for Watchman FLX patients). Increased DRT volume seems to be correlated with low TAWSS and elevated RRT. Conclusion This preliminary study suggests that the Amulet device might be associated with improved LA flow dynamics and a potentially lower incidence of DRT compared with the Watchman. However, a larger clinical study is needed to confirm these findings.
Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department
Houghton, Damon E. , Keenan, Megan , Dykhoff, Hayley J. , Campbell, Kyle N., Hall, Marie Boas, Heaton, Heather A. , Thompson, Kristine M., Aranda, Jamie, Balgord, Sarah , Rubin, Jonathan M. , Hanson, Ryan , He, Wei , Cahill, Emily , Heaton, Heather, Thompson, Kristine, Houghton, Damon E , Hall, Marie, Raja, Ali S , Dutta, Sayon , McEvoy, Dustin , Kreuziger, Lisa Baumann , Rosovsky, Rachel

Mayo Clinic

Vascular Medicine | June 16, 2025 | Volume: 30 | Issue: 3 | Pages: 302-308

10.1177/1358863x251337456 | PMID 40521851 Get It

Background: The use of validated risk stratification tools for the workup of suspected pulmonary embolism (PE) is a recommendation of the American Society of Hematology and the American College of Emergency Physicians. Methods: We designed and implemented electronic clinical pretest probability (PTP) tools for use in emergency departments (ED). Overall, 38 EDs (tertiary and regional EDs) in the United States were involved across three health systems. PTP use was analyzed between September 12, 2022 and January 11, 2023 in 270,247 ED visits. PTP use was examined in terms of the percentage of visits for which patients underwent computed tomography pulmonary angiography (CTPA). Each site chose the 3-tier Wells’ score for implementation and Site 2 designed a combined Wells’, pulmonary embolism rule-out criteria (PERC), and YEARS score. Results: At Site 3, forced use resulted in documented PTP scores in 49–53% of ordered CTPAs. At Sites 1 and 2, where PTP scores were optional, documented PTP scores occurred in 2–3% and 1–3% of CTPA orders, respectively. At Site 1, the use of PTP increased slightly over the study period, with signs that PE yield on imaging was also increasing (3.4–5.9%). At Site 2, PE yield on imaging was 9–10%, and it remained similar, with similar use of PTP tools over the study period. PE yield (6–8%) on imaging also remained similar throughout the study at Site 3. Conclusions: Guideline-endorsed PTP scores for PE at three independent health systems in the United States did not increase PE yield on imaging. Novel implementation strategies involving interdisciplinary teams are urgently needed.
Associations Between Esophageal Motility, Reflux, and Lung Mechanics and Function Are Disease-Specific, Both Between and Within Restrictive and Obstructive Lung Disease
Alghubari, Ali, Olson, Caroline , Bradley, Jessica , Cheah, Ramsah, Shah, Sadia , Naser, Abdel-Rahman N, Lee, Augustine S. , DeVault, Kenneth R. , Houghton, Lesley A. , Shah, Sadia Z. , Houghton, L A , Bradley, Jessica

Mayo Clinic

Clinical and Translational Gastroenterology | June 13, 2025 | Volume: 16 | Issue: 9 | Pages: e00874

10.14309/ctg.0000000000000874 | PMID 40512233 Get It

INTRODUCTION Gastroesophageal reflux is common in respiratory disease, but the interplay between gastrointestinal mechanisms that expose individuals to reflux and potentially aspiration, and lung mechanics and function remain incompletely understood. Our aim was to investigate this in patients with chronic obstructive pulmonary disease (COPD) and non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (non-IPF ILD), and compare with our published findings in IPF. METHODS Fifty-seven patients with COPD (aged: 34–75 years) and 64 with non-IPF ILD (22–75 years) who underwent high-resolution impedance manometry and 24-hour pH impedance together with pulmonary function assessment were compared with 35 IPF patients (51–84 years). RESULTS COPD patients were less likely to exhibit ineffective esophageal motility (IEM) and/or absent contractility ( P = 0.009; P = 0.028), and tended to exhibit esophagogastric junction outflow obstruction (EGJOO) and/or hypercontractility ( P = 0.09, P = 0.14) than IPF and non-IPF ILD patients. Notably, integrated relaxation pressure correlated with esophageal length index (ELI) ( P = 0.048) and inspiratory LESP ( P = 0.003), with latter 2 correlating with each other ( P < 0.001). EGJOO patients tended to have fewer proximal reflux events and reduced pulmonary function, with the latter inversely correlating with ELI ( P < 0.05). Non-IPF ILD patients were less likely to exhibit EGJOO than COPD patients ( P = 0.27), and less likely to exhibit IEM ( P = 0.07) than IPF patients. However, those with IEM or EGJOO exhibited greater proportions of reflux events reaching the proximal esophagus than those with normal motility ( P < 0.03), which in contrast to IPF, seemed not to associate with worse pulmonary function. DISCUSSION Associations between esophageal motility, and lung mechanics and function, and consequently reflux, are very disease-specific.
Weighing the evidence on GLP1s and venous thromboembolism
Houghton, Damon E. , Martin, Karlyn A. , Houghton, Damon E

Mayo Clinic

Blood Advances | May 16, 2025 | Volume: 9 | Issue: 10 | Pages: 2458-2459

10.1182/bloodadvances.2025016052 | PMID 40377920 Get It

Characterization of the Aortic Arch in Relation to Stroke after Transcatheter Aortic Valve Replacement
Vogl, Brennan , Vitale, Emily, Zahrt, Elise, Castriota, Fausto, Hatoum, Hoda , Hatoum, Hoda , Saleh, Ghasaq , Russo, Gerardo Lo , Sularz, Agata , Castriota, Fausto , Alkhouli, Mohamad

Mayo Clinic

Journal of the Heart Valve Society | March 26, 2025 | Volume: 2 | Issue: 1 | Pages: 27-35

10.1177/30494826251325568 Get It

Background Stroke remains a concern after transcatheter aortic valve replacement (TAVR). Several studies attempted to identify correlates of stroke but there remains a need for better predictors. Objective This study aims to characterize the aortic arch to identify potential correlates of stroke after TAVR using a patient cohort that includes cases with and without stroke. Methods A retrospective analysis was performed on 52 patients who underwent TAVR at Mayo Clinic and Maria Cecilia Hospital. Of these patients, 26 had a stroke after TAVR and 26 did not (control). Anatomical characterization was performed on each patient. Patient-specific 3D digital models of the ascending aorta, aortic arch, and calcium were created for each patient. Geometrical measurements, including cross-sectional areas, volumes, tortuosity, curvature, and length of the model were recorded. Results There was no significant difference in the various area measurements between the two groups, but the aortic arch cross-sectional area ratio (cerebral ostia cross-sectional areas/arch cross-sectional area) was significantly higher in the stroke group. Additionally, there was no significant difference in tortuosity, curvature, aortic volume, and length of the aorta. Aortic valve calcium score, aorta calcium, and aortic arch type (I, II, or III) were not significantly different between the groups. The prevalence of a bovine arch (BA) configuration was significantly higher in the stroke group (46% vs 8% control, p < 0.05). Conclusion Aortic arch cross-sectional area ratio and BA variant were the most significant correlates of stroke after TAVR.
Warfarin Dose Management Using Offline Deep Reinforcement Learning
Ji, Hannah , Gill, Matthew, Draper, Evan , Liedl, David , Hodge, David O. , Casanegra, Ana I. , Casanegra, Ana I , Houghton, Damon E.

Mayo Clinic

IEEE Journal of Biomedical and Health Informatics | February 24, 2025 | Volume: 29 | Issue: 7 | Pages: 5219-5228

10.1109/jbhi.2025.3545384 | PMID 40031866 Get It

Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis
Keenan, Megan , Dykhoff, Hayley J. , Hall, Marie Boas, Campbell, Kyle N., Cahill, Emily , Hanson, Ryan , McEvoy, Dustin , He, Wei , Kreuziger, Lisa Baumann , Hall, Marie, Dutta, Sayon , Rosovsky, Rachel , Houghton, Damon E.

Mayo Clinic

American Journal of Medical Quality | February 11, 2025 | Volume: 40 | Issue: 2 | Pages: 38-43

10.1097/jmq.0000000000000223 | PMID 39930618 Get It

Guidelines for diagnosing pulmonary embolism (PE) start with a risk assessment using a pretest probability (PTP) tool, followed by D-dimer testing or computed tomography pulmonary angiography (CTPA) depending on risk. The project aimed to develop an electronic clinical quality measure (eCQM) to encourage broader use of a validated PTP scoring tool in emergency departments (EDs) to more accurately diagnose PE and to reduce unnecessary CTPAs. To identify a value set to accurately identify CTPA and abnormal D-dimer tests using standard classification systems and clinical vocabularies (ie, Current Procedural Terminology [CPT], Logical Observation Identifiers Names and Codes [LOINC], systematized nomenclature of medicine clinical terms [SNOMED CT]) across 3 academic United States health care systems. A comprehensive value set to identify CTPAs was selected, which contained 31 codes. Additionally, each health care system had unique, site-specific codes to more granularly identify CTPAs. Three health care systems representing 38 EDs from across the country submitted data from all ED encounters between September 12, 2022, and January 11, 2023. Imaging types were reviewed from each of the CPT codes and LOINC. The project evaluated whether a D-dimer was obtained using CPT and LOINC and whether the D-dimer result was elevated using SNOMED CT. The number of ED encounters, PTP use, and diagnosis of PE using different codes were determined. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value for selected codes were calculated. Over a 4-month study period, 270,214 encounters were included from 38 EDs. 11,794 ED encounters with CTPAs during the study period, using the site-specific codes were identified. The comprehensive value set had a PPV of 63.4%. Restricting the CTPA value set to CPT code 71275 or LOINC 88322-3 improved the PPV to 82% with 100% sensitivity and 99% specificity. The restricted value set captured the highest proportion of relevant site-specific codes. D-dimer values were identified using LOINC codes 48065-7 and 91556-1 at Site 1 and 48067-3 at Site 2. SNOMED CT codes were not used at any site to identify elevated D-dimer results. Different D-dimer tests with different normal ranges were used at each site, and only one site provided an abnormal flag for D-dimer results. Heterogeneity in the use of nationally standardized codes for labs and imaging tests limits the ability to measure and compare quality across health care organizations for CTPA and D-dimer results. Restricting the identification of CTPA to CPT Code 71275 or LOINC 88322-3 resulted in high sensitivity and specificity, but false positives remain. Additionally, coding for an abnormal D-dimer test result is not standardized across institutions. Therefore, the currently available value sets cannot be used to develop eCQMs whose aim is to evaluate whether CTPA is ordered appropriately based on the PTP risk level and laboratory testing.